PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
58 hedge funds and large institutions have $339M invested in Prevail Therapeutics Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+12
Holders Change %
+26.09%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
14
Increased
25
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$13.8M |
| 2 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
$3.56M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
$3.07M |
| 4 |
AG
Artal Group
Luxembourg
|
$2.44M |
| 5 |
QF
QVT Financial
New York
|
$1.63M |
